secwatch.observer — SEC 8-K summary
======================================

Issuer:     Processa Pharmaceuticals, Inc. (PCSA)
CIK:        0001533743
Form:       8-K
Filed at:   2025-06-30T23:59:59+00:00
Accession:  0001641172-25-017185
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 1.01, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Processa amends Yuhan license; annual meeting adjourned for lack of quorum
--------------------------------------------------------------------------

- Amendment No. 1 to License Agreement with Yuhan Corporation effective June 11, 2025, linked to term sheet with Intact Therapeutics dated June 17, 2025.
- Annual meeting on June 30, 2025 adjourned due to insufficient quorum; reconvened for July 30, 2025 at 1:00 PM in Hanover, MD.
- Record date remains May 1, 2025; previously submitted proxies and votes remain valid without further action.
- No financial or operational details of the Yuhan amendment or Intact Therapeutics term sheet were disclosed in the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1533743/000164117225017185/0001641172-25-017185-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1533743/000164117225017185/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-017185

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer